Back

Acute procedural safety of dual-energy ablation for atrial fibrillation:a systematic review and meta-analysis

13 April 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation tools: procedural outcomes (2) Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Mircea Ioan Alexandru Bistriceanu

Bucharest (Romania)

6 More presentations in this session

Presentation thumbnail
Beyond pulmonary vein isolation: impact of posterior wall and SVC isolation in a zero-fluoroscopy, ICE-guided PFA workflow
Mr G. Pontes Saad (Delray Beach, US)
Abstract Slides Video
Presentation thumbnail
One-year clinical outcomes after dual-energy ablation for atrial fibrillation: a systematic review and meta-analysis
Doctor A. Deaconu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Technological evolution as an independent predictor of pulmonary vein durability after radiofrequency ablation
Doctor D. Kranyak (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Pulmonary vein isolation using a novel dual-energy (RF-PF) ablation catheter: procedural effectiveness and safety in a real-world cohort
Doctor I. Chakarov (Bad Neustadt a. d. Saale, DE)
Abstract Slides Video
Presentation thumbnail
Balloon-in-basket PFA: strong on the veins, gentle on the blood - inflammatory, hemolytic and myocardial biomarker response
Doctor S. Hatahet (Luebeck, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation tools: procedural outcomes (2)

The Event

Event poster

EHRA 2026

13 April 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
One-year clinical outcomes after dual-energy ablation for atrial fibrillation: a systematic review and meta-analysis
thumbnail
Congress Presentation
Discussant review - SmartfIRE
thumbnail
Congress Presentation
Pulmonary vein isolation using a novel dual-energy (RF-PF) ablation catheter: procedural effectiveness and safety in a real-world cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources